GENNEX LABORATORIES
|
The Current P/S Ratio of GENNEX LABORATORIES is 1.61.
| Share Price | ₹12.1 | Sep 04,2026 |
| Market Cap | ₹294.4 Cr | |
| Sales-TTM | ₹183.1 Cr | TTM-Consolidated Results |
| Price/Sales | 1.61x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of GENNEX LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹294.4 Cr] as on Sep 04,2026
(/) Sales [ ₹183.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.61x ]
Thus, for GENNEX LABORATORIES , the investors are currently willing to pay '1.61 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GENNEX LABORATORIES !
The chart below summarizes the trend in P/S Ratio of GENNEX LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of GENNEX LABORATORIES
PS Ratio Performance Analysis for GENNEX LABORATORIES
- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.01x.
- GENNEX LABORATORIES 's operated at median p/e ratio of 1.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2024 at 4.14x.
- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 0.83x.
How does GENNEX LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| GENNEX LABORATORIES | 183.1 | 1.61 | 294.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.61 | 455,634.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.51 | 241,576.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.73 | 184,478.0 |
| CIPLA LTD | 28,324.4 | 3.95 | 111,888.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.90 | 96,322.1 |
| MANKIND PHARMA LTD | 14,737.9 | 6.53 | 96,179.6 |
| LUPIN LTD | 29,966.6 | 3.22 | 96,528.8 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.91 | 111,820.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.72 | 95,127.2 |
| LAURUS LABS LTD | 7,269.6 | 13.68 | 99,417.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GENNEX LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.61x |
| Max industry PS | 21.51x |
| Median industry PS | 3.95x |
| Average industry PS | 7.22x |
You may also like the below Video Courses